Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.

Helms MW, Packeisen J, August C, Schittek B, Boecker W, Brandt BH, Buerger H.

J Pathol. 2005 Jul;206(3):366-76.

PMID:
15892165
[PubMed - indexed for MEDLINE]
2.

Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.

Badve S, Nakshatri H.

J Clin Pathol. 2009 Jan;62(1):6-12. doi: 10.1136/jcp.2008.059899. Epub 2008 Sep 15. Review.

PMID:
18794199
[PubMed - indexed for MEDLINE]
3.

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.

Hodi Z, Chakrabarti J, Lee AH, Ronan JE, Elston CW, Cheung KL, Robertson JF, Ellis IO.

J Clin Pathol. 2007 Mar;60(3):299-302. Epub 2006 May 26. Review.

PMID:
16731591
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Molecular profiling of breast cancer: portraits but not physiognomy.

Brenton JD, Aparicio SA, Caldas C.

Breast Cancer Res. 2001;3(2):77-80. Epub 2000 Dec 18. Review.

PMID:
11250749
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Modulation of estrogen receptor alpha activity and expression during breast cancer progression.

Kerdivel G, Flouriot G, Pakdel F.

Vitam Horm. 2013;93:135-60. doi: 10.1016/B978-0-12-416673-8.00004-6. Review.

PMID:
23810005
[PubMed - indexed for MEDLINE]
6.

Oestrogen-dependent regulation of miRNA biogenesis: many ways to skin the cat.

Gupta A, Caffrey E, Callagy G, Gupta S.

Biochem Soc Trans. 2012 Aug;40(4):752-8. doi: 10.1042/BST20110763. Review.

PMID:
22817728
[PubMed - indexed for MEDLINE]
7.

PET imaging of oestrogen receptors in patients with breast cancer.

van Kruchten M, de Vries EG, Brown M, de Vries EF, Glaudemans AW, Dierckx RA, Schröder CP, Hospers GA.

Lancet Oncol. 2013 Oct;14(11):e465-75. doi: 10.1016/S1470-2045(13)70292-4. Review.

PMID:
24079874
[PubMed - indexed for MEDLINE]
8.

Circulating tumour cells: insights into tumour heterogeneity.

Hayes DF, Paoletti C.

J Intern Med. 2013 Aug;274(2):137-43. doi: 10.1111/joim.12047. Review.

PMID:
23844916
[PubMed - indexed for MEDLINE]
9.

Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Craig Jordan V, Lewis-Wambi J, Kim H, Cunliffe H, Ariazi E, Sharma CG, Shupp HA, Swaby R.

Breast. 2007 Dec;16 Suppl 2:S105-13. Epub 2007 Aug 24. Review.

PMID:
17719781
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Pioneer factors in hormone-dependent cancers.

Jozwik KM, Carroll JS.

Nat Rev Cancer. 2012 May 4;12(6):381-5. doi: 10.1038/nrc3263. Review.

PMID:
22555282
[PubMed - indexed for MEDLINE]
11.

Applications of microarray technology in breast cancer research.

Cooper CS.

Breast Cancer Res. 2001;3(3):158-75. Epub 2001 Mar 20. Review.

PMID:
11305951
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targeting oestrogen to kill the cancer but not the patient.

Lewis JS, Cheng D, Jordan VC.

Br J Cancer. 2004 Mar 8;90(5):944-9. Review.

PMID:
14997187
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Deblois G, Giguère V.

Nat Rev Cancer. 2013 Jan;13(1):27-36. doi: 10.1038/nrc3396. Epub 2012 Nov 29. Review.

PMID:
23192231
[PubMed - indexed for MEDLINE]
14.

Clinical relevance of apoptotic markers in breast cancer not yet clear.

Jager JJ, Jansen RL, Arends JW.

Apoptosis. 2002 Aug;7(4):361-5. Review.

PMID:
12101395
[PubMed - indexed for MEDLINE]
15.

The hypoxic tumour microenvironment and metastatic progression.

Subarsky P, Hill RP.

Clin Exp Metastasis. 2003;20(3):237-50. Review.

PMID:
12741682
[PubMed - indexed for MEDLINE]
16.

The significance of the senescence pathway in breast cancer progression.

Pare R, Yang T, Shin JS, Lee CS.

J Clin Pathol. 2013 Jun;66(6):491-5. doi: 10.1136/jclinpath-2012-201081. Epub 2013 Mar 28. Review.

PMID:
23539738
[PubMed - indexed for MEDLINE]
17.

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis.

Knowles HJ, Harris AL.

Breast Cancer Res. 2001;3(5):318-22. Epub 2001 Jul 17. Review.

PMID:
11597321
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells.

Tyson JJ, Baumann WT, Chen C, Verdugo A, Tavassoly I, Wang Y, Weiner LM, Clarke R.

Nat Rev Cancer. 2011 Jun 16;11(7):523-32. doi: 10.1038/nrc3081. Review.

PMID:
21677677
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cadmium a metalloestrogen: are we convinced?

Silva N, Peiris-John R, Wickremasinghe R, Senanayake H, Sathiakumar N.

J Appl Toxicol. 2012 May;32(5):318-32. doi: 10.1002/jat.1771. Epub 2011 Dec 12. Review.

PMID:
22161274
[PubMed - indexed for MEDLINE]
20.

Tumour-associated carbohydrate antigens in breast cancer.

Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P.

Breast Cancer Res. 2010;12(3):204. doi: 10.1186/bcr2577. Epub 2010 Jun 8. Review.

PMID:
20550729
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk